2025-02-27 |
2025-02-25 |
PS
Planned sale
|
REUVERS DANIEL L.
Non-Executive Director
|
28,338
-11.7%
14.18
USD 401,850
|
28,338
-11.7%
|
14.18
|
USD 401,850
|
|
2025-02-27 |
2025-02-25 |
S
Sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
6,468
-7.7%
14.40
USD 93,160
|
6,468
-7.7%
|
14.40
|
USD 93,160
|
|
2025-02-27 |
2025-02-25 |
PS
Planned sale
|
Birkemeyer Elaine M.
Chief Financial Officer
Officer
|
2,066
-2.0%
14.51
USD 29,980
|
2,066
-2.0%
|
14.51
|
USD 29,980
|
|
2025-02-24 |
2025-02-24 |
PS
Planned sale
|
REUVERS DANIEL L.
Non-Executive Director
|
10,938
-4.3%
14.55
USD 159,147
|
10,938
-4.3%
|
14.55
|
USD 159,147
|
|
2025-02-24 |
2025-02-24 |
PS
Planned sale
|
Birkemeyer Elaine M.
Chief Financial Officer
Officer
|
3,778
-3.5%
14.70
USD 55,538
|
3,778
-3.5%
|
14.70
|
USD 55,538
|
|
2025-02-24 |
2025-02-24 |
S
Sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
4,830
-5.4%
14.65
USD 70,753
|
4,830
-5.4%
|
14.65
|
USD 70,753
|
|
2024-08-14 |
2024-08-12 |
S
Sale
|
Ferstler Sherri Lee
Senior VP, Sales
Officer
|
1,550
-3.8%
13.07
USD 20,263
|
1,550
-3.8%
|
13.07
|
USD 20,263
|
|
2024-05-20 |
2024-05-16 |
S
Sale
|
Birkemeyer Elaine M.
Chief Financial Officer
Officer
|
3,041
-4.7%
13.68
USD 41,590
|
3,041
-4.7%
|
13.68
|
USD 41,590
|
|
2024-05-10 |
2024-05-08 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
2,500
-9.0%
14.06
USD 35,150
|
2,500
-9.0%
|
14.06
|
USD 35,150
|
|
2024-05-08 |
2024-05-06 |
S
Sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
815
-1.3%
14.37
USD 11,713
|
815
-1.3%
|
14.37
|
USD 11,713
|
|
2024-02-29 |
2024-02-29 |
PS
Planned sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
1,396
-0.6%
15.25
USD 21,289
|
1,396
-0.6%
|
15.25
|
USD 21,289
|
|
2024-02-29 |
2024-02-29 |
PS
Planned sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
243
-0.4%
15.25
USD 3,706
|
243
-0.4%
|
15.25
|
USD 3,706
|
|
2024-02-29 |
2024-02-27 |
PS
Planned sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
4,689
-1.9%
15.60
USD 73,148
|
4,689
-1.9%
|
15.60
|
USD 73,148
|
|
2024-02-29 |
2024-02-27 |
PS
Planned sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
1,091
-1.7%
15.58
USD 17,001
|
1,091
-1.7%
|
15.58
|
USD 17,001
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
2,015
-3.1%
15.91
USD 32,049
|
2,015
-3.1%
|
15.91
|
USD 32,049
|
|
2024-02-27 |
2024-02-26 |
PS
Planned sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
6,239
-2.5%
15.81
USD 98,645
|
6,239
-2.5%
|
15.81
|
USD 98,645
|
|
2024-02-27 |
2024-02-23 |
PS
Planned sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
2,249
-4.0%
14.80
USD 33,278
|
2,249
-4.0%
|
14.80
|
USD 33,278
|
|
2024-02-27 |
2024-02-23 |
PS
Planned sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
5,378
-2.7%
14.85
USD 79,853
|
5,378
-2.7%
|
14.85
|
USD 79,853
|
|
2023-08-09 |
2023-08-07 |
S
Sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
1,062
-0.8%
20.53
USD 21,808
|
1,062
-0.8%
|
20.53
|
USD 21,808
|
|
2023-05-16 |
2023-05-12 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
4,400
-13.7%
21.86
USD 96,184
|
4,400
-13.7%
|
21.86
|
USD 96,184
|
|
2023-05-10 |
2023-05-08 |
PS
Planned sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
786
-2.1%
18.65
USD 14,659
|
786
-2.1%
|
18.65
|
USD 14,659
|
|
2023-05-10 |
2023-05-08 |
PS
Planned sale
|
PAULS ERIC
Senior VP, Sales
Officer
|
550
-1.8%
18.55
USD 10,200
|
550
-1.8%
|
18.55
|
USD 10,200
|
|
2023-03-03 |
2023-03-01 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
1,391
-2.8%
14.10
USD 19,613
|
1,391
-2.8%
|
14.10
|
USD 19,613
|
|
2023-02-28 |
2023-02-28 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
251
-0.5%
14.58
USD 3,660
|
251
-0.5%
|
14.58
|
USD 3,660
|
|
2023-02-28 |
2023-02-28 |
S
Sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
700
-0.5%
14.56
USD 10,189
|
700
-0.5%
|
14.56
|
USD 10,189
|
|
2023-02-28 |
2023-02-28 |
S
Sale
|
PAULS ERIC
Senior VP, Sales
Officer
|
72
-0.2%
14.54
USD 1,047
|
72
-0.2%
|
14.54
|
USD 1,047
|
|
2023-02-28 |
2023-02-28 |
S
Sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
135
-0.4%
14.58
USD 1,968
|
135
-0.4%
|
14.58
|
USD 1,968
|
|
2023-02-28 |
2023-02-27 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
3,801
-7.0%
15.36
USD 58,399
|
3,801
-7.0%
|
15.36
|
USD 58,399
|
|
2023-02-28 |
2023-02-27 |
S
Sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
6,387
-4.8%
15.27
USD 97,533
|
6,387
-4.8%
|
15.27
|
USD 97,533
|
|
2023-02-28 |
2023-02-27 |
S
Sale
|
PAULS ERIC
Senior VP, Sales
Officer
|
1,401
-4.4%
15.33
USD 21,477
|
1,401
-4.4%
|
15.33
|
USD 21,477
|
|
2023-02-28 |
2023-02-27 |
S
Sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
2,162
-5.5%
15.39
USD 33,276
|
2,162
-5.5%
|
15.39
|
USD 33,276
|
|
2022-08-10 |
2022-08-08 |
S
Sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
1,020
-1.3%
9.18
USD 9,364
|
1,020
-1.3%
|
9.18
|
USD 9,364
|
|
2022-08-08 |
2022-08-04 |
B
Purchase
|
BURKE WILLIAM W
Non-Executive Director
|
4,900
+25.1%
9.15
USD 44,835
|
4,900
+25.1%
|
9.15
|
USD 44,835
|
|
2022-05-23 |
2022-05-19 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
1,100
-5.3%
10.12
USD 11,132
|
1,100
-5.3%
|
10.12
|
USD 11,132
|
|
2022-05-10 |
2022-05-06 |
S
Sale
|
PAULS ERIC
Senior VP, Sales
Officer
|
600
-3.2%
13.03
USD 7,819
|
600
-3.2%
|
13.03
|
USD 7,819
|
|
2022-05-10 |
2022-05-06 |
PS
Planned sale
|
Burns Kristie
Sr. VP Mktg & Clinical Affairs
Officer
|
999
-4.4%
13.04
USD 13,023
|
999
-4.4%
|
13.04
|
USD 13,023
|
|
2022-03-09 |
2022-03-07 |
PS
Planned sale
|
Moen Brent
Chief Financial Officer
Officer
|
176
-0.3%
20.64
USD 3,633
|
176
-0.3%
|
20.64
|
USD 3,633
|
|
2022-03-03 |
2022-03-01 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
1,632
-3.0%
20.33
USD 33,179
|
1,632
-3.0%
|
20.33
|
USD 33,179
|
|
2022-02-28 |
2022-02-28 |
S
Sale
|
REUVERS DANIEL L.
President and CEO
Executive Director
|
877
-1.1%
19.78
USD 17,350
|
877
-1.1%
|
19.78
|
USD 17,350
|
|
2022-02-28 |
2022-02-28 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
624
-1.1%
19.85
USD 12,383
|
624
-1.1%
|
19.85
|
USD 12,383
|
|
2021-06-28 |
2021-06-24 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
6,761
-44.2%
55.00
USD 371,855
|
6,761
-44.2%
|
55.00
|
USD 371,855
|
|
2021-05-17 |
2021-05-13 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
800
-13.7%
52.08
USD 41,664
|
800
-13.7%
|
52.08
|
USD 41,664
|
|
2021-03-09 |
2021-03-05 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
174
-0.7%
47.33
USD 8,235
|
174
-0.7%
|
47.33
|
USD 8,235
|
|
2021-03-09 |
2021-03-05 |
S
Sale
|
Rishe Bryan
SVP, Sales
Officer
|
196
-0.5%
47.15
USD 9,242
|
196
-0.5%
|
47.15
|
USD 9,242
|
|
2021-03-02 |
2021-02-28 |
S
Sale
|
Moen Brent
Chief Financial Officer
Officer
|
1,429
-5.2%
50.91
USD 72,747
|
1,429
-5.2%
|
50.91
|
USD 72,747
|
|
2021-03-02 |
2021-02-28 |
S
Sale
|
Rishe Bryan
SVP, Sales
Officer
|
1,062
-2.7%
50.90
USD 54,056
|
1,062
-2.7%
|
50.90
|
USD 54,056
|
|
2021-01-06 |
2021-01-04 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
1,500
-20.4%
45.13
USD 67,695
|
1,500
-20.4%
|
45.13
|
USD 67,695
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
1,500
-20.4%
37.50
USD 56,250
|
1,500
-20.4%
|
37.50
|
USD 56,250
|
|
2020-06-12 |
2020-06-10 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-5.3%
44.77
USD 104,314
|
2,330
-5.3%
|
44.77
|
USD 104,314
|
|
2020-05-28 |
2020-05-26 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-5.1%
50.10
USD 116,733
|
2,330
-5.1%
|
50.10
|
USD 116,733
|
|
2020-05-15 |
2020-05-13 |
PS
Planned sale
|
BURKE WILLIAM W
Non-Executive Director
|
550
-8.6%
49.94
USD 27,467
|
550
-8.6%
|
49.94
|
USD 27,467
|
|
2020-05-13 |
2020-05-11 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-4.9%
49.22
USD 114,683
|
2,330
-4.9%
|
49.22
|
USD 114,683
|
|
2020-04-30 |
2020-04-29 |
PS
Planned sale
|
Mattys Gerald R.
Chief Executive Officer
Executive Director
|
11,785
-4.8%
56.14
USD 661,604
|
11,785
-4.8%
|
56.14
|
USD 661,604
|
|
2020-04-30 |
2020-04-29 |
PS
Planned sale
|
Mattys Gerald R.
Chief Executive Officer
Executive Director
|
28,115
-10.3%
55.48
USD 1,559,702
|
28,115
-10.3%
|
55.48
|
USD 1,559,702
|
|
2020-04-30 |
2020-04-28 |
PS
Planned sale
|
Mattys Gerald R.
Chief Executive Officer
Executive Director
|
100
-0.0%
54.95
USD 5,495
|
100
-0.0%
|
54.95
|
USD 5,495
|
|
2020-04-29 |
2020-04-27 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-4.6%
52.66
USD 122,698
|
2,330
-4.6%
|
52.66
|
USD 122,698
|
|
2020-04-15 |
2020-04-13 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-4.4%
47.26
USD 110,116
|
2,330
-4.4%
|
47.26
|
USD 110,116
|
|
2020-03-27 |
2020-03-25 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,331
-4.3%
40.00
USD 93,240
|
2,331
-4.3%
|
40.00
|
USD 93,240
|
|
2020-03-12 |
2020-03-10 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-4.1%
43.75
USD 101,938
|
2,330
-4.1%
|
43.75
|
USD 101,938
|
|
2020-03-09 |
2020-03-05 |
PS
Planned sale
|
Mattys Gerald R.
Chief Executive Officer
Executive Director
|
560
-0.2%
48.49
USD 27,152
|
560
-0.2%
|
48.49
|
USD 27,152
|
|
2020-03-09 |
2020-03-05 |
PS
Planned sale
|
Moen Brent
Chief Financial Officer
Officer
|
175
-0.7%
48.64
USD 8,512
|
175
-0.7%
|
48.64
|
USD 8,512
|
|
2020-03-09 |
2020-03-05 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
180
-0.2%
48.67
USD 8,761
|
180
-0.2%
|
48.67
|
USD 8,761
|
|
2020-03-09 |
2020-03-05 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
204
-0.4%
48.87
USD 9,969
|
204
-0.4%
|
48.87
|
USD 9,969
|
|
2020-02-27 |
2020-02-25 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-6.0%
55.75
USD 129,898
|
2,330
-6.0%
|
55.75
|
USD 129,898
|
|
2020-02-24 |
2020-02-20 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
2,106
-3.5%
63.62
USD 133,984
|
2,106
-3.5%
|
63.62
|
USD 133,984
|
|
2020-02-12 |
2020-02-10 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-5.7%
58.63
USD 136,608
|
2,330
-5.7%
|
58.63
|
USD 136,608
|
|
2020-02-10 |
2020-02-06 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
2,106
-3.3%
59.17
USD 124,612
|
2,106
-3.3%
|
59.17
|
USD 124,612
|
|
2020-01-28 |
2020-01-24 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,330
-5.4%
58.19
USD 135,583
|
2,330
-5.4%
|
58.19
|
USD 135,583
|
|
2020-01-27 |
2020-01-23 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
2,106
-3.2%
57.21
USD 120,484
|
2,106
-3.2%
|
57.21
|
USD 120,484
|
|
2020-01-14 |
2020-01-10 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
2,331
-5.1%
68.77
USD 160,303
|
2,331
-5.1%
|
68.77
|
USD 160,303
|
|
2020-01-13 |
2020-01-09 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
2,106
-3.1%
68.02
USD 143,249
|
2,106
-3.1%
|
68.02
|
USD 143,249
|
|
2019-12-27 |
2019-12-26 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
127
-0.2%
71.04
USD 9,022
|
127
-0.2%
|
71.04
|
USD 9,022
|
|
2019-12-27 |
2019-12-26 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
500
-0.7%
70.40
USD 35,202
|
500
-0.7%
|
70.40
|
USD 35,202
|
|
2019-12-27 |
2019-12-26 |
PS
Planned sale
|
Folkes Robert J.
Chief Operating Officer
Officer
|
1,479
-2.1%
69.30
USD 102,502
|
1,479
-2.1%
|
69.30
|
USD 102,502
|
|
2019-12-26 |
2019-12-26 |
PS
Planned sale
|
Rishe Bryan
SVP, Sales
Officer
|
305
-0.7%
70.81
USD 21,597
|
305
-0.7%
|
70.81
|
USD 21,597
|
|